EL
VRTX icon

EWA LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

EWA LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
492
+12
+3% +$5.32K 0.04% 255
2026
Q1 		$215K Buy
+480
New +$224K 0.05% 232
2025
Q3 		– Sell
-681
Closed -$303K – 245
2025
Q2 		$303K Buy
681
+97
+17% +$44.7K 0.1% 114
2025
Q1 		$283K Sell
584
-9
-2% -$4.19K 0.11% 101
2024
Q4 		$239K Buy
593
+32
+6% +$14.8K 0.09% 122
2024
Q3 		$272K Buy
561
+62
+12% +$29.8K 0.1% 109
2024
Q2 		$245K Buy
499
+20
+4% +$8.68K 0.1% 101
2024
Q1 		$203K Buy
+479
New +$202K 0.09% 116

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EWA LLC's VRTX Position: Q2 2026 in Review

EWA LLC increased its Vertex Pharmaceuticals (VRTX) stake by 2.5% in Q2 2026, buying an estimated $5.32K and bringing the position to 492 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #255.

EWA LLC first reported a position in VRTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $303K in Q2 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • EWA LLC held 492 shares of Vertex Pharmaceuticals worth $245K as of Q2 2026.
  • EWA LLC bought 12 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.32K.
  • Vertex Pharmaceuticals made up 0.04% of EWA LLC's portfolio in Q2 2026, its #255 holding.
  • EWA LLC first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • EWA LLC's Vertex Pharmaceuticals position peaked at $303K in Q2 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.